Role of Smad and Non-Smad Signals in the Development of Th17 and Regulatory T Cells (49.3)

Song Guo Zheng,Ling Lu,Julie Wang,Feng Zhang,Yang Chai,David Brand,Xuehao Wang,David Horwitz,Wei Shi

DOI: https://doi.org/10.4049/jimmunol.184.supp.49.3

2010-01-01

The Journal of Immunology

Abstract:Abstract While TGF-β is essential for the development of peripherally induced Foxp3+ regulatory T (iTreg) and Th17 cells, the intracellular signaling mechanism by which TGF-β regulates development of both cell subsets is less well understood. Using Smad2 lymphocyte conditional knock out and Smad3 knock out mice, we report that neither Smad2 nor Smad3 deficiency abrogates TGF-β-dependent iTreg induction by a deacetylase inhibitor Trichostatin A (TsA) in vivo although loss of Smad2 or Smad3 partially reduces iTreg induction in vitro. Similarly, Smad2 and Smad3 have a redundant role in development of Th17 in vitro and in experimental autoimmune encephalomyelitis (EAE). In addition, ERK and/or JNK pathways were shown to be involved in regulating iTregs, while the p38 pathway predominately modulates Th17 and EAE induction. Therefore, selective targeting of these intracellular TGF-β signaling pathways during iTreg and Th17 cell development may lead to the development of therapies in treating autoimmune and other chronic inflammatory diseases.